Kent and Medway Medical School
11 imported, source-linked research records. Published in the last five years.
11 matching research records
Topic: Acarbose. Only records linked to Kent and Medway Medical School are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–11 of 11 matching records. Counts update as records arrive.
New-onset prostate cancer in type 2 diabetes mellitus exposed to the SGLT2I, DPP4I and GLP1a: A population-based cohort study
November 27, 2023 · 2 citations · Open access
Open original record →Compare SGLT2I versus non-SGLT2I users in type-2 diabetic mellitus patients on GLP-1 receptor agonist: A population-based and machine learning causal inference analysis
November 7, 2023 · 2 citations · Open access
Open original record →Comparing the risks of new-onset gastric cancer or gastric diseases in type 2 diabetes mellitus patients exposed to SGLT2I, DPP4I or GLP1A: a population-based cohort study
July 5, 2023 · 0 citations · Open access
Open original record →Sodium‐glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new‐onset overall cancer in Type 2 diabetes mellitus: A population‐based study
May 6, 2023 · 37 citations · Open access
Open original record →Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong
March 31, 2023 · 24 citations · Open access
Open original record →Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study
September 5, 2022 · 6 citations · Open access
Open original record →Sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new-onset overall cancer in type 2 diabetes mellitus: a population-based study
July 22, 2022 · 3 citations · Open access
Open original record →Lower Risks of Incident Colorectal Cancer in SGLT2i Users Compared to DPP4i Users: A Propensity Score-matched Study with Competing Risk Analysis
July 18, 2022 · 1 citations · Open access
Open original record →Risk of New-Onset Prostate Cancer for Metformin Versus Sulfonylurea Use in Type 2 Diabetes Mellitus: A Propensity Score–Matched Study
June 1, 2022 · 26 citations · Open access
Open original record →Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong
February 10, 2022 · 48 citations · Open access
Open original record →Incident Heart Failure and Myocardial Infarction in Sodium-Glucose Cotransporter-2 vs. Dipeptidyl Peptidase-4 Inhibitor Users
February 7, 2022 · 28 citations · Open access
Open original record →